Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
CATALYST PHARMACEUTICALS, INC. | Director | Restricted Stock Units | 73.8K | $1.06M | $14.37 | Dec 8, 2023 | Direct |
CATALYST PHARMACEUTICALS, INC. | Director | Options to purchase common stock | 69.5K | Dec 8, 2023 | Direct | ||
Avidity Biosciences, Inc. | Director | Stock Option (Right to Buy) | 13.5K | Jun 13, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
RNA | Avidity Biosciences, Inc. | Jun 13, 2024 | 1 | $0 | 4 | Jun 14, 2024 | Director |
CPRX | CATALYST PHARMACEUTICALS, INC. | Dec 8, 2023 | 2 | $0 | 4 | Dec 12, 2023 | Director |
RNA | Avidity Biosciences, Inc. | Jun 15, 2023 | 1 | $0 | 4 | Jun 20, 2023 | Director |
CPRX | CATALYST PHARMACEUTICALS, INC. | May 25, 2023 | 0 | $0 | 3 | Jun 5, 2023 | Director |
RNA | Avidity Biosciences, Inc. | Jun 15, 2022 | 1 | $0 | 4 | Jun 17, 2022 | Director |